Abstract
Background/Aim. Hormone D (vitamin D) plays an important role in immunoregulation and musculoskeletal metabolism. The aim of this study was to assess the impact of alfacalcidol (ILD3) or prednisone use on muscle function and disease activity in active rheumatoid arthritis (RA). Methods. The study included 67 RA patients with the active disease, disease activity score (DAS28) > 3.2, on the highest tolerable methotrexate (MTX) dose during last 3 months. Data collected were: DAS 28, muscle function tests [chair rising test (CRT) timed up and go (TUG), 6 minutes walk (6MWT), tandem walk (TW)], efficacy and safety laboratory tests. At enrollment, patients were randomly assigned to three-month supplementation with 1 ?g (group A1) or 2 ?g (group A2) or 3 ?g (group A3) of 1?D3 daily or prednisone (group C) 20 mg daily, for the first month and 10 mg afterward, in addition to MTX. Results. After the treatment, we found highly significantly reduced disease activity in all four treatment arms (DAS28 p < 0.01). 1?D3 2 ?g (A2 group, n = 19) treated patients significantly improved muscle function (TUG, 6MWT), while 1?D3 3 ?g treated (A3, n = 16) improved 6MWT (p < 0.05), and CRT (p < 0.01). Serum 25(OH)D3 significantly decreased in the group C (p < 0.01), in contrast to its changes obtained in alfacalcidol treated ones. Conclusion. 1?D3 2 ?g and 3 ?g daily is as effective as prednisone (mean 13.3 mg daily) in RA activity control and also has the additional favorable impact on muscle function.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Military Medical and Pharmaceutical Journal of Serbia
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
